| Authors: |
Anstee JE; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Feehan KT; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Opzoomer JW; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Dean I; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK., Muller HP; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Bahri M; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Cheung TS; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Liakath-Ali K; Centre for Stem Cells and Regenerative Medicine, King's College London, London SE1 9RT, UK., Liu Z; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Choy D; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Caron J; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Sosnowska D; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Beatson R; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Muliaditan T; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., An Z; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Gillett CE; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Lan G; Cancer Research UK Cambridge Research Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 ORE, UK., Zou X; Cancer Research UK Cambridge Research Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 ORE, UK., Watt FM; Centre for Stem Cells and Regenerative Medicine, King's College London, London SE1 9RT, UK., Ng T; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK; UCL Cancer Institute, University College London, London WC1E 6DD, UK., Burchell JM; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Kordasti S; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK; Haematology Department, Guy's Hospital, London SE1 9RT, UK., Withers DR; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK., Lawrence T; Centre for Inflammation Biology and Cancer Immunology, School of Immunology & Microbial Sciences, King's College London, London SE1 1UL, UK; Aix Marseille University, CNRS, INSERM, CIML, Marseille, France; Henan Key Laboratory of Immunology and Targeted Therapy, School of Laboratory Medicine, Xinxiang Medical University, Xinxiang, China., Arnold JN; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK. Electronic address: james.arnold@kcl.ac.uk. |
